International Immunology Advance Access originally published online on November 2, 2006
International Immunology 2007 19(1):11-18; doi:10.1093/intimm/dxl116
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heme oxygenase-1 is not required for mouse regulatory T cell development and function
Instituto Gulbenkian de Ciência, Rua da Quinta Grande, 6, Apartado 14, 2780-901 Oeiras, Portugal
Correspondence to: J. Demengeot; E-mail: jocelyne{at}igc.gulbenkian.pt
CD4 regulatory T cells (Treg) ensure peripheral tolerance to self-antigens and limit the deleterious effects associated with inflammatory and immune responses by mechanisms that remain to be fully understood. The enzyme heme oxygenase-1 (HO-1), through its known anti-inflammatory activity, is a candidate for a functional role in Treg activity. We compared wild-type and heme oxygenase-1-deficient (hmox-1/) mice in order to assess the role of HO-1 in mouse Treg development and function under physiologic conditions. The frequency of CD25+ and Foxp3+ Treg was similar in hmox-1/ and hmox-1+/+ mice. More importantly, CD4+CD25+ Treg purified from either hmox-1/ or hmox-1+/+ mice were equally efficient in controlling the proliferation in vitro and the expansion in vivo of CD4+CD25 T cells, whether or not these responder cells expressed HO-1. In addition, induction of expression of HO-1 in vivo did not affect Treg suppressor function. As shown before, expression of HO-1 was higher in Treg than in naive T cells; however, naturally activated Foxp3 T cells displayed equal amount of HO-1 mRNA as Treg. Finally, we conclude that under physiological conditions in mice, Treg development, maintenance and function are independent of HO-1 activity.
Keywords: inflammation, regulatory T cells, tolerance
Transmitting editor: R. Flavell
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Blancou and I. Anegon Editorial: Heme oxygenase-1 and dendritic cells: what else? J. Leukoc. Biol., February 1, 2010; 87(2): 185 - 187. [Full Text] [PDF] |
||||
![]() |
M. Biburger, G. Theiner, M. Schadle, G. Schuler, and G. Tiegs Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity J. Leukoc. Biol., February 1, 2010; 87(2): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moreau, M. Hill, P. Thebault, J. Y. Deschamps, E. Chiffoleau, C. Chauveau, P. Moullier, I. Anegon, B. Alliot-Licht, and M. C. Cuturi Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates FASEB J, September 1, 2009; 23(9): 3070 - 3077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. George, A. Braun, T. M. Brusko, R. Joseph, S. Bolisetty, C. H. Wasserfall, M. A. Atkinson, A. Agarwal, and M. H. Kapturczak Suppression by CD4+CD25+ Regulatory T Cells Is Dependent on Expression of Heme Oxygenase-1 in Antigen-Presenting Cells Am. J. Pathol., July 1, 2008; 173(1): 154 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Lee, W. Gao, S. Mazzola, M. N. Thomas, E. Csizmadia, L. E Otterbein, F. H. Bach, and H. Wang Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells FASEB J, November 1, 2007; 21(13): 3450 - 3457. [Abstract] [Full Text] [PDF] |
||||


